When was Strategikon founded?

Strategikon was founded in 2017 and raised its 1st funding round 4 years after it was founded.

Where is Strategikon located?

Strategikon is headquartered in San Francisco, United States.

Who is the current CEO of Strategikon?

Anca Copaescu of Strategikon. They have also founded 1 company.

How many employees does Strategikon have?

As of May 31, 2026, the latest employee count at Strategikon is 36.

Is Strategikon a funded company?

Strategikon is a funded company, having raised an undisclosed amount across 2 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Apr 22, 2021.

When was the latest funding round of Strategikon?

Strategikon's latest funding was a $***** Venture Debt round on May 08, 2025, with participation from 1 investor.

Where does Strategikon rank among its competitors?

Strategikon ranks 26th amongst 204 active competitors, of which 6 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Strategikon, which secured $2.29M in May, 2025.

Who are the top competitors of Strategikon?

Strategikon's top competitors include Vasta Global, PharmAla Biotech and S-Cubed. Among them, Strategikon secured the most recent funding round in May, 2025.

Strategikon - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of SaaS solutions for clinical trial management. These solutions streamline clinical trial processes, focusing on financial management, vendor management, and procurement. The offerings automate budgeting, RFP/RFI management, contract generation, and vendor qualification, improving efficiency and reducing costs. The platform provides real-time insights into trial finances and vendor performance, enabling data-driven decision-making. Services include consulting, managed services, and implementation support to ensure successful adoption and ongoing operational excellence.

Website: strategikon.com
Email ID: *****@strategikonpharma.com

Key Metrics

Founded Year

2017

Location

San Francisco, United States

Stage

Series A

Latest Funding Round

Venture Debt, May 08, 2025, $*****

Investors

Osage Venture Partners & 11 more

Ranked

26^th among 204 active competitors

Employee Count

36 as on May 31, 2026

Similar Companies

Vasta Global & 245 more

View Strategikon's full profile

Strategikon has raised funding over 2 rounds. Its first funding round was on Apr 22, 2021. Its latest funding round was a Venture Debt round on May 08, 2025 for $*****. 1 investor participated in its latest round. Strategikon has 12 institutional investors.

Here is the list of recent funding rounds of Strategikon:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 08, 2025	2026167	Venture Debt	1502057	9620052	2398606	2864660
Apr 22, 2021	5959650	Series A	4565980	6512986	Osage Venture Partners	Wing Venture Capital & 6 more

Access funding benchmarks and valuations. Sign up today!

View details of Strategikon's funding rounds and investors

The founders of Strategikon are Anca Copaescu and Paulo Carvalho. Anca Copaescu is the CEO of Strategikon.

Here are the details of Strategikon's key team members:

Anca Copaescu: Co-Founder & CEO of Strategikon.
Paulo Carvalho: Co-Founder & COO of Strategikon.

View details of Strategikon's Founder profiles and Board Members

Strategikon's employee count trend

Strategikon has 36 employees as of May 26. Here is Strategikon's employee count trend over the years:

Uncover Strategikon's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Strategikon include Vasta Global, PharmAla Biotech and S-Cubed. Here is the list of Top 10 competitors of Strategikon, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Vasta Global 2010, Mumbai (India), Acquired	Offers clinical research consulting	-	-	57/100
2nd	PharmAla Biotech 2021, Toronto (Canada), Public	Provider of biomanufacturing, regulatory, and financial services	-	-	43/100
3rd	S-Cubed 2007, Copenhagen (Denmark), Acquired	Clinical development consultancy services in areas such as biometrics, CDISC, and regulatory affairs	-	-	42/100
4th	Pharmefex 2014, Bellevue (United States), Unfunded	CMC consulting for biologics, cell, and gene therapies	-	-	42/100
5th	MIMYK 2017, Bengaluru (India), Seed	Developer of medical devices and provider of product design services	$292K	92 Angels, Indian Angel Network & 53 others	38/100
6th	Blue Matter Consulting 2012, San Francisco (United States), Late Stage	Provider of consulting services focused for clinical drug development	-	Baird Capital	38/100
7th	Biomapas 2001, Kaunas (Lithuania), Unfunded	Manufacturer of clinical research for medical devices	-	Carbyne Equity Partners	38/100
8th	TransCelerate BioPharma 2012, Conshohocken (United States), Unfunded	Provider of clinical development consulting services	-	-	38/100
9th	Orchestra Life Sciences 2021, Chesterfield (United States), Unfunded	Provider of technical consultancy for cancer and rare disease therapies	-	-	36/100
10th	MCRA 2004, New York City (United States), Funding Raised	Provider of regulatory, quality assurance and market access services to biopharma sector	-	Caltius Capital Management, Viscogliosi Brothers	35/100
26th	Strategikon 2017, San Francisco (United States), Series A	Provider of SaaS solutions for clinical trial management	-	Wing Venture Capital, Golden Seeds & 10 others	27/100